Busch Matthew C. 4

What Happened
Matthew C. Busch, Vice President, Finance & Chief Accounting Officer at Amgen, had 68 shares of AMGN disposed on May 2, 2026 to satisfy tax withholding obligations tied to equity awards. The transactions consist of 30 shares and 38 shares withheld at $329.82 per share, for total proceeds/withholding of $9,895 and $12,533 respectively (combined ≈ $22,428). This is a routine tax-withholding disposition rather than an open-market sale for investment purposes.

Key Details

• Transaction date: 2026-05-02; Form 4 filed: 2026-05-05.
• Price per share: $329.82. Total shares disposed: 68. Total value: ≈ $22,428.
• Transaction code: F — payment of exercise price or tax liability (tax withholding). These disposals represent shares withheld to cover taxes.
• Footnote: 49 of the shares are Dividend Equivalents (DEs) credited to unvested Restricted Stock Units under Amgen’s 2009 Equity Incentive Plan; DEs are paid in shares on the vesting schedule (with cash for fractional shares).
• Shares owned after the transaction: not disclosed in the provided filing.

Context
This was a withholding event tied to equity compensation (RSUs/DEs), common when awards vest; it does not necessarily signal a change in the insider’s view of the company. The filing identifies the disposals as tax-related (F), not open-market sales.